Interleukin-23 drives innate and T cell-mediated intestinal inflammation
Loading...
Download
Associated Records
Authors
File Licence
Editors
Date
2006-10-01
Source Title
Journal of Experimental Medicine (JEM)
Journal Title
Journal ISSN
Volume Title
Publisher
Rockefeller University Press
Melbourne Authors
Affiliation
Bio21
Document Type
Journal Article
Subject Code
Citation
Hue, S., Ahern, P., Buonocore, S., Kullberg, M. C., Cua, D. J., McKenzie, B. S., Powrie, F. & Maloy, K. J. (2006). Interleukin-23 drives innate and T cell-mediated intestinal inflammation. Journal of Experimental Medicine, 203 (11), pp.2473-2483. https://doi.org/10.1084/jem.20061099.
Access Status
Open Access
Access URL
Open Access URL
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract involving aberrant activation of innate and adaptive immune responses. We have used two complementary models of IBD to examine the roles of interleukin (IL)-12 family cytokines in bacterially induced intestinal inflammation. Our results clearly show that IL-23, but not IL-12, is essential for the induction of chronic intestinal inflammation mediated by innate or adaptive immune mechanisms. Depletion of IL-23 was associated with decreased proinflammatory responses in the intestine but had little impact on systemic T cell inflammatory responses. These results newly identify IL-23 as a driver of innate immune pathology in the intestine and suggest that selective targeting of IL-23 represents an attractive therapeutic approach in human IBD.